ID

13865

Descrizione

VA Augmentation and Switching Treatments for Improving Depression Outcomes; ODM derived from: https://clinicaltrials.gov/show/NCT01421342

collegamento

https://clinicaltrials.gov/show/NCT01421342

Keywords

versioni (1)
  1. 13/03/16 13/03/16 -
Caricato su

13 marzo 2016

DOI

Per favore, per richiedere un accesso.

Licenza

Creative Commons BY 4.0
Commenti del modello :

Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.

Torna ai commenti del modello
Commenti del gruppo di articoli per :

Commenti dell'articolo per :

Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.

Eligibility Major Depressive Disorder NCT01421342

Inglese

Eligibility Major Depressive Disorder NCT01421342

1 moduli  
Inclusion Criteria
Descrizione

Inclusion Criteria

Alias
UMLS CUI
C1512693
dsm-iv diagnosis of single or recurrent, non-psychotic, major depressive disorder
Descrizione

dsm-iv; major depressive disorder

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0220952
UMLS CUI [2]
C1269683
currently taking a selective serotonin reuptake inhibitor (ssri) or serotonin-norepinephrine reuptake inhibitor (snri) or mirtazapine for major depressive disorder
Descrizione

selective serotonin reuptake inhibitor; serotonin-norepinephrine reuptake inhibitor; mirtazapine

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0360105
UMLS CUI [2]
C3537213
UMLS CUI [3]
C0049506
need for "next-step" treatment based on documented suboptimal outcome from current antidepressant treatment for major depressive episode (at least 6 weeks treatment with a qids-c16 >= 16 or at least 8 weeks with a qids-c16 >= 11; and at least 3 weeks at a stable "optimal" dose
Descrizione

antidepressant; therapy major depressive episode

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0003289
UMLS CUI [2,1]
C0087111
UMLS CUI [2,2]
C0154409
age: 18 years of age or older
Descrizione

age

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0001779
Exclusion Criteria
Descrizione

Exclusion Criteria

Alias
UMLS CUI
C0680251
prior inadequate response after an adequate treatment trial or clear cut intolerance to either of the study medications (aripiprazole or bupropion)
Descrizione

hypersensitivity study drugs

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0008972
current treatment with bupropion, aripiprazole or any other antipsychotic agent
Descrizione

antipsychotic agent bupropion aripiprazole

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0040615
UMLS CUI [1,2]
C0085208
UMLS CUI [1,3]
C0299792
lifetime history of bipolar disorder, schizophrenia, schizoaffective disorder, or psychosis not otherwise specified
Descrizione

bipolar disorder; schizophrenia; psychosis

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0005586
UMLS CUI [2]
C0036341
UMLS CUI [3]
C0033975
current diagnosis of dementia
Descrizione

dementia

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0497327
current diagnosis of an eating disorder or a seizure disorder
Descrizione

eating disorder; seizure disorder

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0013473
UMLS CUI [2]
C0014544
high suicide risk currently requiring acute intervention (other than outpatient treatment of depression)
Descrizione

High suicide risk

Tipo di dati

boolean

Alias
UMLS CUI [1]
C1271074
unstable, serious medical condition or one requiring acute medical treatment, or anticipation of hospitalization for extended care
Descrizione

comorbidity; hospitalization

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0009488
UMLS CUI [2]
C0019993
requiring immediate hospitalization for psychiatric disorders
Descrizione

hospitalization psychiatric disorders

Tipo di dati

boolean

Alias
UMLS CUI [1,1]
C0019993
UMLS CUI [1,2]
C0004936
physiologic substance dependence requiring detoxification (excluding nicotine) in the past 30 days (substance abuse is not an exclusion criteria)
Descrizione

drug detoxification; Substance Use Disorder

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0025516
UMLS CUI [2]
C0038586
taking any concomitant medication that contraindicates any of treatment options or augmenting agents known to have an antidepressant effect
Descrizione

concomitant medication

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2347852
concurrent or recent participation (within the last 30 days) in another conflicting clinical trial with a mental health, investigational drug, or medical device intervention
Descrizione

Study Subject Participation Status

Tipo di dati

boolean

Alias
UMLS CUI [1]
C2348568
female - pregnant or lactating or planning to become pregnant
Descrizione

pregnancy; lactating

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
patient was not able or willing to provide informed consent; or changed mind about participating prior to randomization
Descrizione

informed consent

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0021430
patient was not referred to the study
Descrizione

Clinical Research

Tipo di dati

boolean

Alias
UMLS CUI [1]
C0008972
Ritorna all'inizio della pagina

Similar models

Eligibility Major Depressive Disorder NCT01421342

1 moduli
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
C1512693 (UMLS CUI)
dsm-iv; major depressive disorder
Item
dsm-iv diagnosis of single or recurrent, non-psychotic, major depressive disorder
boolean
C0220952 (UMLS CUI [1])
C1269683 (UMLS CUI [2])
selective serotonin reuptake inhibitor; serotonin-norepinephrine reuptake inhibitor; mirtazapine
Item
currently taking a selective serotonin reuptake inhibitor (ssri) or serotonin-norepinephrine reuptake inhibitor (snri) or mirtazapine for major depressive disorder
boolean
C0360105 (UMLS CUI [1])
C3537213 (UMLS CUI [2])
C0049506 (UMLS CUI [3])
antidepressant; therapy major depressive episode
Item
need for "next-step" treatment based on documented suboptimal outcome from current antidepressant treatment for major depressive episode (at least 6 weeks treatment with a qids-c16 >= 16 or at least 8 weeks with a qids-c16 >= 11; and at least 3 weeks at a stable "optimal" dose
boolean
C0003289 (UMLS CUI [1])
C0087111 (UMLS CUI [2,1])
C0154409 (UMLS CUI [2,2])
age
Item
age: 18 years of age or older
boolean
C0001779 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
hypersensitivity study drugs
Item
prior inadequate response after an adequate treatment trial or clear cut intolerance to either of the study medications (aripiprazole or bupropion)
boolean
C0020517 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0008972 (UMLS CUI [1,3])
antipsychotic agent bupropion aripiprazole
Item
current treatment with bupropion, aripiprazole or any other antipsychotic agent
boolean
C0040615 (UMLS CUI [1,1])
C0085208 (UMLS CUI [1,2])
C0299792 (UMLS CUI [1,3])
bipolar disorder; schizophrenia; psychosis
Item
lifetime history of bipolar disorder, schizophrenia, schizoaffective disorder, or psychosis not otherwise specified
boolean
C0005586 (UMLS CUI [1])
C0036341 (UMLS CUI [2])
C0033975 (UMLS CUI [3])
dementia
Item
current diagnosis of dementia
boolean
C0497327 (UMLS CUI [1])
eating disorder; seizure disorder
Item
current diagnosis of an eating disorder or a seizure disorder
boolean
C0013473 (UMLS CUI [1])
C0014544 (UMLS CUI [2])
High suicide risk
Item
high suicide risk currently requiring acute intervention (other than outpatient treatment of depression)
boolean
C1271074 (UMLS CUI [1])
comorbidity; hospitalization
Item
unstable, serious medical condition or one requiring acute medical treatment, or anticipation of hospitalization for extended care
boolean
C0009488 (UMLS CUI [1])
C0019993 (UMLS CUI [2])
hospitalization psychiatric disorders
Item
requiring immediate hospitalization for psychiatric disorders
boolean
C0019993 (UMLS CUI [1,1])
C0004936 (UMLS CUI [1,2])
drug detoxification; Substance Use Disorder
Item
physiologic substance dependence requiring detoxification (excluding nicotine) in the past 30 days (substance abuse is not an exclusion criteria)
boolean
C0025516 (UMLS CUI [1])
C0038586 (UMLS CUI [2])
concomitant medication
Item
taking any concomitant medication that contraindicates any of treatment options or augmenting agents known to have an antidepressant effect
boolean
C2347852 (UMLS CUI [1])
Study Subject Participation Status
Item
concurrent or recent participation (within the last 30 days) in another conflicting clinical trial with a mental health, investigational drug, or medical device intervention
boolean
C2348568 (UMLS CUI [1])
pregnancy; lactating
Item
female - pregnant or lactating or planning to become pregnant
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
informed consent
Item
patient was not able or willing to provide informed consent; or changed mind about participating prior to randomization
boolean
C0021430 (UMLS CUI [1])
Clinical Research
Item
patient was not referred to the study
boolean
C0008972 (UMLS CUI [1])
Ritorna all'inizio della pagina 

Contatto

Si prega di utilizzare questo modulo per feedback, domande e suggerimenti per miglioramenti.

I campi contrassegnati da * sono obbligatori.

Aiuto

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial